-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Merck & Co., Inc. quarterly Deferred State and Local Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Merck & Co., Inc. Deferred State and Local Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$107M, a 17.1% increase year-over-year.
- Merck & Co., Inc. Deferred State and Local Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$107M.
Deferred State and Local Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred State and Local Income Tax Expense (Benefit), Quarterly Data (USD)